Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Abaxx Announces Post Abaxx Exchange Launch Investor Events
-
AngioDynamics to Participate in Upcoming Investor Conferences
-
Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference
-
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
-
Akebia Therapeutics to Present at Upcoming Investor Conferences
-
Newell Rubbermaid (NWL) PT Raised to $12 at Canaccord Genuity
-
DocGo Announces Upcoming Participation at Canaccord Genuity 44th Annual Growth Conference
-
Vivid Seats to Participate in Canaccord Genuity’s 2024 Growth Conference
-
Lion One Announces Closing of Financings
-
Advantage Solutions Announces Date for its 2Q’24 Financial Results and Conference Call
-
DexCom (DXCM) PT Lowered to $89 at Canaccord Genuity
-
Loop Industries to Attend the Canaccord Genuity 44th Annual Growth Conference Taking Place August 13-15th, 2024
-
ICF to Present at the Canaccord Genuity 44th Annual Growth Conference
-
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Silver Elephant Closes 1st Tranche of Private Placement Raising Gross Proceeds of $1,111,584
-
OpenAI enters Google-dominated search market with SearchGPT
-
Recommended All Share Offer For Trinity Exploration & Production Plc by Touchstone Exploration Inc. to be Effected by Means of a Scheme of Arrangement under Part 26 of the Companies Act 2006
-
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
LifeMD to Participate in Two Investor Conferences During August
-
Form 8.3 - [MATTIOLI WOODS PLC - 24 07 2024] - (CGWL)
-
Canaccord Genuity Downgrades Rogers Communications (RCI/B:CN) (RCI) to Hold
-
ServiceNow (NOW) PT Raised to $850 at Canaccord Genuity
-
Edwards Lifesciences (EW) PT Lowered to $77 at Canaccord Genuity
-
Boston Scientific (BSX) PT Raised to $88 at Canaccord Genuity
-
Canaccord Genuity Upgrades Alarum Technologies (ALAR) to Buy
-
BlackBerry to Participate in Upcoming Investor Events
-
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
-
Form 8.3 - [LOK'N STORE GROUP PLC - 23 07 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 23 07 2024] - (CGWL)
-
Form 8.3 - [MATTIOLI WOODS PLC - 23 07 2024] - (CGWL)
-
Form 8.3 - [GUSBOURNE PLC - Opening Disclosure - 22 07 2024] - (CGAML) - Updated
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA)
-
Iris Energy Ltd. (IREN) PT Raised to $15 at Canaccord Genuity
-
HealthStream (HSTM) PT Raised to $28 at Canaccord Genuity
-
Enphase Energy (ENPH) PT Lowered to $140 at Canaccord Genuity
-
Alpha Exploration Announces $6.0 Million Private Placement Offering of Ordinary Shares
-
Spotify (SPOT) PT Raised to $400 at Canaccord Genuity
-
Form 8.3 - [GUSBOURNE PLC - Opening Disclosure - 22 07 2024] - (CGAML)
-
Form 8.3 - [MATTIOLI WOODS PLC - 22 07 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 22 07 2024] - (CGWL)
-
Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
-
10X Genomics (TXG) PT Lowered to $32 at Canaccord Genuity
-
SharkNinja (SN) PT Raised to $90 at Canaccord Genuity
-
Riveron Acquires Yantra, Adding Strength to Supporting Technology Needs of CFOs
-
Golden Horse Extends Term of Two Key Agreements
-
Canaccord Genuity Starts MP Evans Group PLC (MPE:LN) at Buy
-
Verona Pharma (VRNA) PT Raised to $37 at Canaccord Genuity

